Media & Communication

29k International AB is a Swedish non-profit tech foundation offering a free mental health app with science-based psychological tools and peer support programs, partnering with institutions including Karolinska Institute and Harvard University. The organization has been involved in clinical research as a digital therapeutic support platform in studies exploring mental health outcomes alongside psychedelic and other novel interventions.

The ALPS Foundation (Awareness Lectures on Psychedelics in Switzerland) is a Swiss non-profit, founded in 2021 by students from the universities of Lausanne and Geneva, that promotes evidence-based education and research on psychedelics. It organises the annual ALPS Conference (Awareness Lectures on Psychedelic Science), a key event in the Swiss psychedelic-science calendar, alongside lectures and student-forum activities for professionals and the public.

Public-service international news organization with recurring coverage of psychedelic clinical evidence, regulation, and public-health implications.

Biopharma trade publication reporting on psychedelic clinical trial outcomes, approvals, setbacks, and market context.

Breaking Convention is a UK-based biennial conference on psychedelic consciousness, first held in 2011, that convenes researchers, clinicians, artists, activists and practitioners for multidisciplinary dialogue across the science, culture, history and policy of psychedelics. It is one of Europe's largest and longest-running psychedelic conferences.

DoubleBlind is a biannual print magazine and digital media company covering psychedelics and related topics including mental health and environmental justice. Its site says it began as a print magazine and now publishes journalism, offers classes and workshops, and runs a monthly membership programme focused on harm reduction education and community.

Biopharma trade news outlet covering psychedelic biotech pipelines, financing, trial results, and regulatory milestones.

The European College of Neuropsychopharmacology (ECNP) is a non-profit scientific association dedicated to the science and treatment of disorders of the brain. Founded in 1987 and based in Utrecht, it runs Europe's largest applied neuroscience meeting, supports thematic research networks (including a dedicated Psychedelic Research Network), and delivers education through its online Knowledge Hub.

Biotechnology industry publication with recurring coverage of psychedelic drug-development programs and deal activity.

European biotech trade outlet with recurring coverage of psychedelic startups, R&D programs, and financing developments.

Lucid News is an independent, online-first journalism outlet covering psychedelics and other emerging medicines across science, policy, culture and business. It publishes reporting, commentary and analysis for both general and professional audiences, with particular attention to the social, ethical and equity dimensions of the psychedelic field.

MAPS, the Multidisciplinary Association for Psychedelic Studies, is a U.S.-based 501(c)(3) nonprofit research and educational organization founded in 1986. It works nationally and with a broader global audience to develop medical, legal, and cultural contexts for the careful use of psychedelics and marijuana. Its core activities include research, education, advocacy, and convening the field through large public events. In psychedelic medicine and policy, MAPS positions itself as an advocate for legal access, drug policy reform, harm reduction, and health equity. Its Policy & Advocacy work includes legislative advocacy, community organizing, and impact litigation, and it has also launched work on access for system-impacted people and broader health equity in the legal psychedelic ecosystem. Current documented initiatives include the Psychedelic Science conference series, the Health Equity Program, The Zendo Project, and Ask MAPS, which handles public inquiries about therapy, research, and policy reform.

MIND Foundation is a non-profit mental health organisation based in Berlin. It focuses on psychedelic research and education, and says it advances the legal, safe, evidence-based and accessible use of psychedelics in therapy and human development. The organisation also runs training and educational programmes, including Augmented Psychotherapy Training.

Microdose Psychedelic Insights is an online publication and media company focused on the business of psychedelics. Its site says it provides industry events, market intelligence, original evidence-based content, strategy, community, and online courses covering topics such as microdosing, MDMA, ketamine, psychedelic counselling, addiction treatment, and classic psychedelics. It describes itself as a guide to psychedelics and says its mission is to shift perceptions of psychedelic medicine.

U.S. public media network with recurring psychedelic reporting across science, health, policy, and patient-outcome narratives.

Nucleus Holding is a psychedelic-sector venture studio, launched out of Iter Investments, that builds and operates companies serving the psychedelic ecosystem. Its subsidiaries have included the industry media platform Psychedelic Invest and the psychedelic information database Neuly.

OPEN Foundation is a Dutch non-profit organisation based in Amsterdam. It focuses on psychedelic research, education, conferences, workshops, and continuing education courses. Its activities aim to help integrate psychedelics ethically and responsibly into science, healthcare, and society.

Psychedelic Alpha (Pα) is an independent, data-driven psychedelic media, research and advisory platform, founded in 2020 by Josh Hardman and based in London. It publishes the widely read weekly Psychedelic Bulletin newsletter alongside closely followed trackers of psychedelic drug development and of psychedelic law and policy, and provides advisory and consultancy services to investors, philanthropists, government agencies, startups and established firms. It is known for cutting through hype to surface what matters in the development, regulation and commercialisation of psychedelic medicines.

Psychedelic Invest is a psychedelic-industry media and market-intelligence platform providing news, company coverage, data and investor-oriented reporting on the sector. It operates as part of Nucleus Holding, the psychedelic-sector venture studio launched out of Iter Investments.

Psychedelic Press is an independent UK publisher, active since 2008 and based in Wiltshire, focused on the science, history, literature and culture of psychoactive substances and altered states of consciousness. It publishes books alongside a limited-edition print journal (run 2012 to 2023, edited by Robert Dickins and Nikki Wyrd) featuring fiction, non-fiction and scholarship on the psychedelic experience.

Online psychedelic publication with digital media programming, including recurring video/news formats and multimedia coverage.

Psychedelics Today is a United States-based psychedelic media and education organisation. Its website describes it as a source of expert-informed media and education, and it also offers Vital Psychedelic Training, a 12-month accreditation programme for professionals interested in psychedelic practice and integration.

Health and biotech trade publication with sustained reporting on psychedelic clinical development, regulation, and commercialization.

Mainstream international magazine with repeated long-form and news coverage on psychedelic medicine development and policy shifts.

TRIPP is a digital wellness company that builds immersive extended-reality (VR and AR) experiences for mindfulness, mental wellbeing and psychedelic-inspired guided journeys. It sits in the psychedelic-adjacent digital-therapeutics space, using technology rather than pharmacology to support altered states and mental-health outcomes.

Global general-news outlet with sustained reporting and commentary on psychedelic science, policy reform, safety, and cultural adoption.

Major U.S. news publication with ongoing reporting on psychedelic health research, therapeutic access, legal frameworks, and safety concerns.

Third Wave is a US-based online education platform focused on psychedelics and microdosing. Its site says it provides research-based content, training, and community resources to support intentional and responsible psychedelic use. The company presents itself as a public benefit corporation and says it was founded by Paul F. Austin.

Digital-first global media brand with extensive psychedelic-focused journalism spanning science explainers, policy analysis, and culture reporting.

Wavepaths is a digital platform, founded by the neuroscientist Mendel Kaelen, that delivers adaptive, generative music designed for psychedelic and other therapy sessions. Its software responds in real time to the arc of a session, giving therapists tools to shape the musical environment that supports psychedelic-assisted and consciousness-altering therapeutic work.

Pharmaceutical industry publication that includes periodic coverage and commentary on psychedelic therapies and implementation challenges.